Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Joshua McClure
Founder, CEO and Chairman at Maxwell Biosciences
Joshua is an engineer with over 20 years of experience as a CEO. He is a multi-patent inventor including anti-viral applications of Maxwell’s platform. His background includes leading engineering teams, as well as military intelligence and commercial applications. He is a pioneer in the field of plasma proteomics and biomimetics. He has a wide ranging interest in physics, information theory and nanobiology. He is a graduate of the USAF Academy, with a B.S. in Management. He holds a Masters of Business Administration from the University of Massachusetts.
Visit website: https://maxwellbiosciences.com/team
See also
Details last updated 21-Oct-2022
Joshua McClure News
Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022Some really exciting developments with quite a few in clinical trials
Joshua McClure is also referenced in the following:
ARDD 2023 - 10th Aging Research & Drug Discovery Meeting
28-Aug-2023 to 01-Sep-2023
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
Longevity Summit Dublin 2023
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
Joshua McClure Blog Posts
24-Aug-2023
Highlights from Longevity Summit Dublin 2023
Key points and slides from the leading longevity conference hosted by Aubrey de Grey
